有结直肠癌家族史患者的CT结肠成像筛查:与平均风险成人的比较及对指南的启示
本研究比较了有与无美国癌症协会定义结直肠癌家族史的无症状成人在CT结肠成像筛查中的病变检出率。家族史组所有≥6 mm非微小息肉检出率较高(23.7% vs 15.5%,p=0.007),结肠镜转诊率也较高(16.0% vs 10.5%,p=0.035),但进展期腺瘤(4.5% vs 3.2%,p=0.357)和癌(0.0% vs 0.4%,p=0.999)频率无显著增加。作者认为这些发现支持将CTC作为有家族史成人的一线筛查选择。
要点
- 家族史组≥6 mm非微小息肉检出率显著高于无家族史组(23.7% vs 15.5%,p=0.007)。
- 家族史组结肠镜转诊率显著更高(16.0% vs 10.5%,p=0.035),但进展期腺瘤和癌的频率无显著增加。
- 两组阳性率差异(11.5% vs 4.3%,p<0.001)主要源于无结直肠癌相关性的非肿瘤性发现。
核心结论
- 尽管家族史组CTC阳性和结肠镜转诊率较高,但临床相关的进展期肿瘤和癌的频率未充分增加以排除CTC筛查,这些发现支持将CTC作为有结直肠癌家族史成人的一线筛查选项。
研究设计与样本
- 在134个月内连续登记的CTC队列比较,有家族史组n=156(女性88例[56.4%],男性68例[43.6%],平均年龄56.3岁),无家族史组n=8857(女性4757例[53.7%],男性4100例[46.3%],平均年龄56.6岁);家族史按美国癌症协会指南定义(一级亲属60岁前诊断或两名一级亲属任何年龄诊断)。
关键影像表现/征象
- 家族史组 vs 无家族史组所有≥6 mm非微小息肉报告频率为23.7% vs 15.5%(p=0.007)。
- 家族史组 vs 无家族史组小息肉(6-9 mm)频率为13.5% vs 9.1%(p=0.068)。
- 家族史组 vs 无家族史组大息肉(≥10 mm)频率为10.2% vs 6.5%(p=0.068)。
诊断标准与关键数值
- 家族史组 vs 无家族史组结肠镜转诊率为16.0% vs 10.5%(p=0.035)。
- 家族史组 vs 无家族史组证实的进展期腺瘤频率为4.5% vs 3.2%(p=0.357)。
- 家族史组 vs 无家族史组非进展期腺瘤频率为5.1% vs 2.6%(p=0.070)。
- 家族史组 vs 无家族史组癌频率为0.0% vs 0.4%(p=0.999)。
- 家族史组 vs 无家族史组阳性率差异为11.5% vs 4.3%(p<0.001),主要归因于无结直肠癌相关性的非肿瘤性发现。
临床应用与阅片要点
- 对有结直肠癌家族史的无症状成人,CTC筛查中≥6 mm非微小息肉检出率和结肠镜转诊率较高,但进展期腺瘤和癌的频率无显著增加。
- 家族史组与无家族史组阳性率差异主要来自小增生性息肉、憩室病和CTC假阳性等无结直肠癌相关性的发现。
- 作者认为这些发现支持将CTC作为有结直肠癌家族史成人的一线筛查选项。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purposes of this study were to compare rates of lesion detection at CT colonographic (CTC) screening of adults without symptoms who had and who did not have a family history of colorectal cancer according to American Cancer Society guidelines and to consider the clinical implications.
MATERIALS AND METHODS: Over 134 months, consecutively registered CTC cohorts of adults without symptoms who had (n = 156; 88 [56.4%] women; 68 [43.6%] men; mean age, 56.3 years) and who did not have (n = 8857; 4757 [53.7%] women; 4100 [46.3%] men; mean age, 56.6 years) an American Cancer Society-defined family history of colorectal cancer (first-degree relative with diagnosis before age 60 years or two first-degree relatives with diagnosis at any age) were compared for relevant colorectal findings.
RESULTS: For the family history versus no family history cohorts, the frequency of all nondiminutive polyps (≥ 6 mm) reported at CTC was 23.7% versus 15.5% (p = 0.007); small polyps (6-9 mm), 13.5% versus 9.1% (p = 0.068); and large polyps (≥ 10 mm), 10.2% versus 6.5% (p = 0.068). The rate of referral for colonoscopy was greater for the family history cohort (16.0% vs 10.5%; p = 0.035). However, the frequencies of proven advanced adenoma (4.5% vs 3.2%; p = 0.357), nonadvanced adenoma (5.1% vs 2.6%; p = 0.070), and cancer (0.0% vs 0.4%; p = 0.999) were not significantly increased. The difference in positive rates between the two cohorts (11.5% vs 4.3%; p < 0.001) was primarily due to nonneoplastic findings of no colorectal cancer relevance, such as small hyperplastic polyps, diverticular disease, and false-positive CTC findings.
CONCLUSION: Although the overall CTC-positive and colonoscopy referral rates were higher in the family history cohort, the clinically relevant frequencies of advanced neoplasia and cancer were not sufficiently increased to preclude CTC screening. These findings support the use of CTC as a front-line screening option in adults with a family history of colorectal cancer.
引用
- Pickhardt PJ, Mbah I, Pooler BD, et al. CT Colonographic Screening of Patients With a Family History of Colorectal Cancer: Comparison With Adults at Average Risk and Implications for Guidelines. AJR Am J Roentgenol. 2017. PMID: 28125785. doi:10.2214/AJR.16.16724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。